Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12065669rdf:typepubmed:Citationlld:pubmed
pubmed-article:12065669lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:12065669lifeskim:mentionsumls-concept:C0178719lld:lifeskim
pubmed-article:12065669lifeskim:mentionsumls-concept:C0034830lld:lifeskim
pubmed-article:12065669lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:12065669lifeskim:mentionsumls-concept:C1444748lld:lifeskim
pubmed-article:12065669lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:12065669lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:12065669lifeskim:mentionsumls-concept:C1698986lld:lifeskim
pubmed-article:12065669lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:12065669lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:12065669pubmed:issue3lld:pubmed
pubmed-article:12065669pubmed:dateCreated2002-6-14lld:pubmed
pubmed-article:12065669pubmed:abstractTextNeuronal nicotinic acetylcholine receptors (nAChR) can regulate several neuronal processes through Ca2+-dependent mechanisms. The versatility of nAChR-mediated responses presumably reflects the spatial and temporal characteristics of local changes in intracellular Ca2+ arising from a variety of sources. The aim of this study was to analyse the components of nicotine-evoked Ca2+ signals in SH-SY5Y cells, by monitoring fluorescence changes in cells loaded with fluo-3 AM. Nicotine (30 microm) generated a rapid elevation in cytoplasmic Ca2+ that was partially and additively inhibited (40%) by alpha7 and alpha3beta2* nAChR subtype selective antagonists; alpha3beta4* nAChR probably account for the remaining response (60%). A substantial blockade (80%) by CdCl2 (100 microm) indicates that voltage-operated Ca2+ channels (VOCC) mediate most of the nicotine-evoked response, although the alpha7 selective antagonist alpha-bungarotoxin (40 nm) further decreased the CdCl2- resistant component. The elevation of intracellular Ca2+ levels provoked by nicotine was sustained for at least 10 min and required the persistent activation of nAChR throughout the response. Intracellular Ca2+ stores were implicated in both the initial and sustained nicotine-evoked Ca2+ responses, by the blockade observed after ryanodine (30 microm) and the inositoltriphosphate (IP3)-receptor antagonist, xestospongin-c (10 microm). Thus, nAChR subtypes are differentially coupled to specific sources of Ca2+: activation of nAChR induces a sustained elevation of intracellular Ca2+ levels which is highly dependent on the activation of VOCC, and also involves Ca2+ release from ryanodine and IP3-dependent intracellular stores. Moreover, the alpha7, but not alpha3beta2* nAChR, are responsible for a fraction of the VOCC-independent nicotine-evoked Ca2+ increase that appears to be functionally coupled to ryanodine sensitive Ca2+ stores.lld:pubmed
pubmed-article:12065669pubmed:languageenglld:pubmed
pubmed-article:12065669pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:citationSubsetIMlld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12065669pubmed:statusMEDLINElld:pubmed
pubmed-article:12065669pubmed:monthMaylld:pubmed
pubmed-article:12065669pubmed:issn0022-3042lld:pubmed
pubmed-article:12065669pubmed:authorpubmed-author:WonnacottSusa...lld:pubmed
pubmed-article:12065669pubmed:authorpubmed-author:Dajas-Bailado...lld:pubmed
pubmed-article:12065669pubmed:authorpubmed-author:MoggAdrian...lld:pubmed
pubmed-article:12065669pubmed:issnTypePrintlld:pubmed
pubmed-article:12065669pubmed:volume81lld:pubmed
pubmed-article:12065669pubmed:ownerNLMlld:pubmed
pubmed-article:12065669pubmed:authorsCompleteYlld:pubmed
pubmed-article:12065669pubmed:pagination606-14lld:pubmed
pubmed-article:12065669pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:meshHeadingpubmed-meshheading:12065669...lld:pubmed
pubmed-article:12065669pubmed:year2002lld:pubmed
pubmed-article:12065669pubmed:articleTitleIntracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells: contribution of voltage-operated Ca2+ channels and Ca2+ stores.lld:pubmed
pubmed-article:12065669pubmed:affiliationDepartment of Biology and Biochemistry, University of Bath, Bath, UK.lld:pubmed
pubmed-article:12065669pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12065669pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12065669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12065669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12065669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12065669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12065669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12065669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12065669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12065669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12065669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12065669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12065669lld:pubmed